Updated
Reviewed by Chandani Patel
Europe Protein Supplements Market Industry Trends and Forecast to 2034: Segmented by (Source, Form, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$3.94 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $5.51 Bn | — | — |
| 2025 (base) | $5.84 Bn | +$325.3 Mn | — |
| 2026 (forecast) | $6.18 Bn | +$344.5 Mn | +5.9% |
| 2027 (forecast) | $6.55 Bn | +$364.8 Mn | +12.1% |
| 2028 (forecast) | $6.93 Bn | +$386.3 Mn | +18.8% |
| 2029 (forecast) | $7.34 Bn | +$409.1 Mn | +25.8% |
| 2030 (forecast) | $7.78 Bn | +$433.2 Mn | +33.2% |
| 2031 (forecast) | $8.24 Bn | +$458.8 Mn | +41.1% |
| 2032 (forecast) | $8.72 Bn | +$485.9 Mn | +49.4% |
| 2033 (forecast) | $9.24 Bn | +$514.5 Mn | +58.2% |
| 2034 (forecast) | $9.78 Bn | +$544.9 Mn | +67.5% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US
$12.66 Bn
Canada
$2.37 Bn
China
$2.19 Bn
Japan
$1.83 Bn
Germany
$1.06 Bn
Brazil
$805.2 Mn
France
$770.1 Mn
UK
$754.4 Mn
Ecuador
$698.7 Mn
Italy
$619.3 Mn
Spain
$604.5 Mn
India
$643.2 Mn
Saudi Arabia
$570.4 Mn
Mexico
$466.3 Mn
Australia
$368.7 Mn
Russia
$293.4 Mn
New Zealand
$274.8 Mn
South Africa
$177.4 Mn
UAE
$130.6 Mn
Egypt
$84.3 Mn
Philippines
$62.6 Mn
Malaysia
$55.2 Mn
Hong Kong
$42.1 Mn
Thailand
$39.5 Mn
Singapore
$33.2 Mn
Kenya
$23.4 Mn
| Market size, 2025 | $5.84 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $9.78 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 5.9% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Source, form and distribution channel (see all) |
| Key players | Glanbia PLC, Abbott Laboratories, Nestle, MusclePharm Corporation, Myprotein (THG) (see all) |
| Regulator in Europe | EMA and EFSASource: European Medicines Agency. Checked 14 Nov 2026.Source: European Food Safety Authority. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Protein supplements provide extra protein from whey, casein or plants, for muscle building, recovery and ageing.
Key segments of the protein Supplements market include source (Whey, Casein and Plant-Based) and form (Powders, Ready-to-Drink and Bars).
Growing interest in prevention, social media trends, ageing consumers, sports nutrition going mainstream and easy online shopping are driving the protein Supplements market.
Personalised nutrition, clinically tested ingredients and new formats such as gummies and drinks give the protein Supplements market strong room to grow.
Mixed scientific evidence, quality and safety concerns, strict health-claim rules and price competition hold back the protein Supplements market.
The protein Supplements market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In the EU, many new medicines are authorised once for every member state by the European Commission, after review by the European Medicines Agency (EMA).[1] In the countries we cover here, medicines are approved by ANSM (France)[2], BfArM (Germany)[3], AIFA (Italy)[4], Ministry of Health (Russia)[5], AEMPS (Spain)[6] and MHRA (UK)[7]. EU law sets common rules for food supplements, and the European Food Safety Authority (EFSA) assesses their health claims.[8] In the countries we cover here, supplement rules come from DGCCRF and ANSES (France)[9], BVL (Germany)[10], Ministry of Health (Italy)[11], Rospotrebnadzor (Russia)[12], AESAN (Spain)[13] and FSA (UK)[14].
[1] European Medicines Agency. Checked 14 Nov 2026.
[2] ANSM, French medicines agency. Checked 14 Nov 2026.
[3] Federal Institute for Drugs and Medical Devices (BfArM). Checked 14 Nov 2026.
[4] Italian Medicines Agency (AIFA). Checked 14 Nov 2026.
[5] Ministry of Health of the Russian Federation. Checked 14 Nov 2026.
[6] Spanish Agency of Medicines and Medical Devices (AEMPS). Checked 14 Nov 2026.
[7] Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.
[8] European Food Safety Authority. Checked 14 Nov 2026.
[9] ANSES. Checked 14 Nov 2026.
[10] Federal Office of Consumer Protection and Food Safety (BVL). Checked 14 Nov 2026.
[11] Italian Ministry of Health. Checked 14 Nov 2026.
[12] Rospotrebnadzor. Checked 14 Nov 2026.
[13] Spanish Agency for Food Safety and Nutrition (AESAN). Checked 14 Nov 2026.
[14] Food Standards Agency. Checked 14 Nov 2026.
Food and supplement rules, labelling and health-claim regulations govern protein Supplements products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in Europe.
What doctors and scientists are doing in Protein Supplements right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
Europe · 3 shared keywords
Europe · 2 shared keywords
Europe · 2 shared keywords
Europe · 2 shared keywords
Europe · 1 shared keyword
Europe · 1 shared keyword
Medical Devices · Europe
Healthcare Services · Europe
Medical Devices · Europe
Pharmaceuticals · Europe
Pharmaceuticals · Europe
Pharmaceuticals · Europe